1.Amlodipine toxicity and lipid emulsion.
Korean Journal of Anesthesiology 2018;71(6):491-492
No abstract available.
Amlodipine*
2.Amlodipine toxicity complicated by concurrent medications.
Bhavna GUPTA ; Sukhyanti KERAI
Korean Journal of Anesthesiology 2018;71(6):489-490
No abstract available.
Amlodipine*
3.Is irrational use of intralipid emulsion justified in amlodipine toxicity?
Bhavna GUPTA ; Sukhyanti KERAI
Korean Journal of Anesthesiology 2019;72(2):191-193
No abstract available.
Amlodipine
4.Real-world effectiveness and safety of single-pill combination of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide in patients with hypertension from the Philippines.
Sison Jorge A. ; Francisco Shari G.
Philippine Journal of Internal Medicine 2014;52(4):202-208
OBJECTIVE: The EXforge Clinical evaluation of amlodlpine and valsarTan in hypErtension (EXCITE) study was designed to evaluate the real-world effectiveness and safety of amlodipine/valsartan (Aml/Val) and amlodipine/valsartan/hydrochlorothiazide (Aml/Val/HCT) single-pill combination (SPC) in patients with hypertension.
METHODOLOGY: This 26-week observational, multicenter, prospective, open-label study included patients aged ? 18 years of age with established diagnosis of hypertension. The change in mean sitting systolic BP (msSBP), diastolic BP (msDBP) from baseline to Week 26, proportion of patients achieving BP goal (msSBP/msDBP <130/80 mmHg and <140/90 mmHg for patients with and without diabetes,respectively) at endpoint, and safety were monitored. Here, we report the data of patients from the Philippines.
RESULTS: Of the total 1,054 patients in the full analysis set (Aml/Val, n=928; Aml/Val/HCTZ, n=126), 923 (87.6%) patients completed the study. The baseline BP was 158.5/96.5 and 167.0/99.5 mmHg in the Aml/Val and Aml/Val/HCTZ groups,respectively. Significant reductions in msSBP and msDBP from baseline to week 26 were observed with both Aml/Val (-31.9/-19.2 mmHg). Adverse events were reported by 8.8% of the patients.
CONCLUSION: The Aml/Val and Aml/Val/HCTZ SPCs were effective in controlling BP and were generally well tolerated in patients with hypertension from the Philippines.
Human ; Male ; Female ; Middle Aged ; Adult ; Young Adult ; Amlodipine ; Amlodipine, Valsartan Drug Combination ; Diabetes Mellitus ; Hydrochlorothiazide ; Hypertension ; Philippines ; Tetrazoles ; Valine ; Valsartan
5.Primarily treatment of hypertension in pregnancy by amlodipin
Journal of Medical and Pharmaceutical Information 1998;9():36-39
61 pregnant women with moderate or severe hypertension (systolic blood pressure: 150 mmHg; diastolic blood pressure: 100 mmHg), the mean age was 32.11 6.16, were involved in a study. All participants have received aldomet (1g/day) and hydralazin (100 mg/day) for a week but their blood pressures were not reduced. In this study, they were treated by amlopidin. The monitoring these pregnant women and their fetuses have shown that amlopidin reduced both diastolic and systolic blood to an allowed level. Drug did not cause renal and liver functional disorder, and not change the glycemia and cholesterolemia but reduce the uremia. The drug did not cause any complications for fetus.
Hypertension
;
Amlodipine
6.Treatment of hypertension by amlodipin in gravidic intoxication
Journal of Medical and Pharmaceutical Information 2000;3():31-35
The open clinical assays method that to evaluate the results of treatment of hypertension by amlodipin in 61 women with gravidic intoxication, ages of from 24 to 46. Results shown that successful rate is 54/61; amlodipin didn't cause dysfunction of liver and kidney, didn't change the concentration of blood glucose and cholesterol but decreased blood urea, drug can induced the headache, dizziness but these symptoms is slight and self-reversible. Regarding foetus, Apgar index can be approached and there is not manifestation of monster and foetus death
Hypertension
;
Amlodipine
7.Effects of valsartan combined with amlodipine or hydrochlorothiazide regimen on blood pressure variation in elderly hypertensive patients.
Ze-bing WU ; Ying ZHANG ; Qi-gui YU ; Cai-xia SUN ; Cun-wu TAO
Chinese Journal of Cardiology 2012;40(1):8-13
OBJECTIVETo compare the effects of valsartan combined with amlodipine or hydrochlorothiazide regimen on blood pressure variation and plasma nitric oxide (NO) and endothelin (ET) in elderly hypertensive patients.
METHODSA total of 61 elderly patients with grade 2 or 3 hypertension were randomized into valsartan + amlodipine (the amlodipine group, n = 31) or valsartan + hydrochlorothiazide (the hydrochlorothiazide group, n = 30) group. Blood lipids, fasting plasma glucose and uric acid were determined before the treatment. 24-hour dynamic blood pressure, NO and ET were monitored at baseline, 8 and 16 weeks after treatment.
RESULTS24 hours blood pressure and daytime blood pressure were similar between two groups at all 3 time points. At 16 weeks, morning systolic blood pressure surge was significantly lower in amlodipine group than in hydrochlorothiazide group [(22.6 ± 8.8) mm Hg (1 mm Hg = 0.133 kPa) vs. (26.3 ± 13.7) mm Hg, P < 0.05]. 24 hours systolic blood pressure variability (SBPV) decreased progressively in both groups [the amlodipine group: (12.5 ± 2.8) mm Hg vs. (10.2 ± 2.2) mm Hg vs. (8.8 ± 1.6) mm Hg, P < 0.01; the hydrochlorothiazide group: (12.5 ± 2.5) mm Hg vs. (10.7 ± 2.2) mm Hg vs. (9.6 ± 2.0) mm Hg, P < 0.01]. Daytime SBPV also decreased progressively in both groups [the amlodipine group: (12.2 ± 3.0) mm Hg vs. (10.1 ± 2.3) mm Hg vs. (8.4 ± 1.9) mm Hg, P < 0.01; the hydrochlorothiazide group: (11.8 ± 2.7) mm Hg vs. (10.4 ± 1.9) mm Hg vs. (9.6 ± 2.2) mm Hg, P < 0.01]. 24 hours diastolic blood pressure variability (DBPV) was significantly reduced post therapy in the amlodipine group [(15.5 ± 3.4) mm Hg vs. (13.0 ± 3.5) mm Hg vs. (12.3 ± 2.5), P < 0.01] but not in the hydrochlorothiazide group. NO increased progressively [(27.3 ± 13.6) µmol/L vs. (47.2 ± 16.3) µmol/L vs. (69.5 ± 18.9) µmol/L in the amlodipine group, P < 0.01; (33.5 ± 13.9) µmol/L vs. (49.7 ± 21.9) µmol/L vs. (66.7 ± 24.7) µmol/L in the hydrochlorothiazide group, P < 0.01] and ET decreased progressively [(45.3 ± 8.0) ng/L vs. (37.4 ± 3.9) ng/L vs. (34.2 ± 4.4) ng/L in the amlodipine group, P < 0.01; (46.6 ± 10.4) ng/L vs. (37.0 ± 5.4) ng/L vs. (36.1 ± 8.2) ng/L in the hydrochlorothiazide group, P < 0.01] in both groups.
CONCLUSIONValsartan in combination with amlodipine or hydrochlorothiazide can both effectively lower BPV in elderly hypertensive patients and improve the vascular endothelial function and the former regimen is more suitable for elderly hypertensive patients.
Aged ; Amlodipine ; therapeutic use ; Blood Pressure ; drug effects ; Drug Therapy, Combination ; Female ; Humans ; Hydrochlorothiazide ; therapeutic use ; Hypertension ; drug therapy ; physiopathology ; Male ; Middle Aged ; Tetrazoles ; therapeutic use ; Treatment Outcome ; Valine ; analogs & derivatives ; therapeutic use ; Valsartan
8.Efficacy and safety of the single pill combination of valsartan 80 mg plus amlodipine 5 mg in mild to moderate essential hypertensive patients without adequate blood pressure control by monotherapy.
Yuan-Nan KE ; Jun HUANG ; Jun-Ren ZHU ; null
Chinese Journal of Cardiology 2009;37(9):794-799
OBJECTIVETo evaluate the efficacy and safety of a once daily valsartan/amlodipine 80/5 mg combination tablet in Chinese mild to moderate hypertensive patients without adequate blood pressure control by monotherapy.
METHODSTwo multicenter, randomized, double-blind, double dummy, active-controlled, parallel group trials were conducted. After a washout period (no medication) of 1-4 weeks, patients with Mean Sitting Diastolic Blood Pressure (MSDBP) > or = 95 mm Hg (1 mm Hg = 0.133 kPa) and < 110 mm Hg received a monotherapy of either Amlodipine 5 mg (in study 1) or valsartan 80 mg (in study 2) for 4 weeks. Patients with MSDBP > or = 90 mm Hg and < 110 mm Hg at the end of the monotherapy period were randomized to receive valsartan/amlodipine 80/5 mg treatment, or continue with the monotherapy.
RESULTSIn study 1, compared with amlodipine 5 mg, valsartan/amlodipine 80/5 mg once daily further reduced mean sitting systolic blood pressure (MSSBP)/MSDBP 4.4/3 mm Hg (P < 0.0001). In study 2, compared with valsartan 80 mg, valsartan/amlodipine 80/5 mg once daily further reduced MSSBP/MSDBP 6.4/4.2 mm Hg (P < 0.0001). The blood pressure (BP) control rates (BP < 140/90 mm Hg) of combination treatment group were 71.0% and 71.2% respectively, and significantly higher than the monotherapy groups in both trials. Incidence of adverse events was comparable in monotherapy and combination therapy groups.
CONCLUSIONOur results showed that valsartan/amlodipine 80/5 mg was superior to amlodipine 5 mg or valsartan 80 mg alone in lowering blood pressure and BP control in patients with mild to moderate hypertension not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. No new or unexpected safety issues were identified with valsartan/amlodipine combination therapy compared with monotherapy.
Adult ; Amlodipine ; administration & dosage ; Antihypertensive Agents ; administration & dosage ; Blood Pressure ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Hypertension ; drug therapy ; Male ; Middle Aged ; Tetrazoles ; administration & dosage ; Valine ; administration & dosage ; analogs & derivatives ; Valsartan
9.Amlodipine monotherapy in patients with essential hypertension.
Kyung Soo KIM ; Jung Hyun KIM ; Hun Kil LIM ; Bang Hun LEE ; Jung Kyoon LEE
The Korean Journal of Critical Care Medicine 1993;8(1):59-63
No abstract available.
Amlodipine*
;
Humans
;
Hypertension*
10.Amlodipin to treat high blood pressure in pregnant intoxication
Journal of Medical Research 2003;0(2):17-21
The results of treatment of high blood presure in pregnant intoxication on 61 pregnant women are as follows: success rate 54/61 (88.52%). Systolic blood pressure and diastolic blood pressure decreased significantly in comparing with the use of Aldomet in combining with Hydralazin (p < 0.05). No sign of liver and kidney failures were reported, no increase of serum glucose and serum cholesterol, blood creatinine decreased nonsignificantly (p > 0.05), uremia decreased significantly. For the fetus, Apgar index was tolerable, no sign of monster and stillbirth. Conclusion: Amlodipin is good drug for treating high blood pressure in pregnant intoxication.
Therapy
;
Amlodipine
;
Pregnant Women
;
Hypertension